lncRNA TMPO antisense RNA 1 promotes the malignancy of cholangiocarcinoma cells by regulating let-7g-5p/ high-mobility group A1 axis

References

• Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383(9935):2168–2179.
   PubMed Web of Science ®Google Scholar
• Bergquist A, Von Seth E. Epidemiology of cholangiocarcinoma. Best Pract Res Clin Gastroenterol. 2015;29(2):221–232.
   PubMed Web of Science ®Google Scholar
• Rizvi S, Khan SA, Hallemeier CL, et al. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15(2):95–111.
   PubMed Web of Science ®Google Scholar
• Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford). 2008;10(2):77–82.
   PubMed Web of Science ®Google Scholar
• Doherty B, Nambudiri VE, Palmer WC. Update on the Diagnosis and Treatment of Cholangiocarcinoma. Curr Gastroenterol Rep. 2017;19(1):2.
   PubMedGoogle Scholar
• Chen J, Huang X, Wang W, et al. LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis. Aging (Albany NY). 2018;10(11):3371–3381.
   PubMedGoogle Scholar
• Li T, Chen Y, Zhang J, et al. LncRNA TUG1 promotes cells proliferation and inhibits cells apoptosis through regulating AURKA in epithelial ovarian cancer cells. Medicine (Baltimore). 2018;97(36):e12131.
   PubMed Web of Science ®Google Scholar
• Fang J, Chen W, Meng XL. LncRNA CASC9 suppressed the apoptosis of gastric cancer cells through regulating BMI1. Pathol Oncol Res. 2020;26(1):475–482.
   PubMed Web of Science ®Google Scholar
• Zhu H, Zhai B, He C, et al. LncRNA TTN-AS1 promotes the progression of cholangiocarcinoma via the miR-320a/neuropilin-1 axis. Cell Death Dis. 2020;11(8):637.
   PubMed Web of Science ®Google Scholar
• Hao WY, Guo LW, Luo J, et al. LncRNA TUG1 promotes growth and metastasis of cholangiocarcinoma cells by inhibiting miR-29a. Cancer Manag Res. 2020;12:11103–11111.
   PubMed Web of Science ®Google Scholar
• Xin Y, He X, Zhao W, et al. LncRNA PCAT6 increased cholangiocarcinoma cell proliferation and invasion via modulating miR-330-5p. Am J Transl Res. 2019;11(9):6185–6195.
   PubMed Web of Science ®Google Scholar
• Liang Z, Zhu B, Meng D, et al. Down-regulation of lncRNA-NEF indicates poor prognosis in intrahepatic cholangiocarcinoma. Biosci Rep. 2019;39(5). DOI:10.1042/BSR20181573.
   Google Scholar
• Li J, Jiang X, Li C, et al. LncRNA-MEG3 inhibits cell proliferation and invasion by modulating Bmi1/RNF2 in cholangiocarcinoma. J Cell Physiol. 2019;234(12):22947–22959.
   PubMed Web of Science ®Google Scholar
• Peng L, Liu YH, Nie S, et al. LncRNA CASC2 inhibits cell proliferation, metastasis and EMT through miR-18a/SOCS5 axis in cholangiocarcinoma. Eur Rev Med Pharmacol Sci. 2020;24(16):8367–8376.
   PubMed Web of Science ®Google Scholar
• He YC, Bi YG, Jiang L. LncRNA TMPO-AS1 promotes proliferation and migration in bladder cancer. Eur Rev Med Pharmacol Sci. 2020;24(17):8740–8746.
   PubMed Web of Science ®Google Scholar
• Yang J, Liang B, Hou S. TMPO-AS1 promotes cervical cancer progression by upregulating RAB14 via sponging miR-577. J Gene Med. 2019;21(11):e3125.
   PubMed Web of Science ®Google Scholar
• Yu X, Lin Q, Liu F, et al. LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p. Int J Immunopathol Pharmacol. 2020;34:2058738420958947.
   Web of Science ®Google Scholar
• Ali Syeda Z, Langden SSS, Munkhzul C, et al. Regulatory mechanism of microRNA expression in cancer. Int J Mol Sci. 2020;21(5):1723.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li TE, Chen M, et al. miR-106b-5p contributes to the lung metastasis of breast cancer via targeting CNN1 and regulating Rho/ROCK1 pathway. Aging (Albany NY). 2020;12(2):1867–1887.
   PubMedGoogle Scholar
• Huang L, Zhang Y, Li Z, et al. MiR-4319 suppresses colorectal cancer progression by targeting ABTB1. United European Gastroenterol J. 2019;7(4):517–528.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Wen J, Peng L, et al. Upregulation of insulin-like growth factor-1 receptor (IGF-1R) reverses the inhibitory effect of let-7g-5p on migration and invasion of nasopharyngeal carcinoma. Med Sci Monit. 2019;25:5747–5756.
   PubMed Web of Science ®Google Scholar
• Zhang XH, Qian Y, Li Z, et al. Let-7g-5p inhibits epithelial-mesenchymal transition consistent with reduction of glioma stem cell phenotypes by targeting VSIG4 in glioblastoma. Oncol Rep. 2016;36(5):2967–2975.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hu L, Zheng Y, et al. HMGA1 in cancer: cancer classification by location. J Cell Mol Med. 2019;23(4):2293–2302.
   PubMed Web of Science ®Google Scholar
• Lund T, Holtlund J, Fredriksen M, et al. On the presence of two new high mobility group-like proteins in HeLa S3 cells. FEBS Lett. 1983;152(2):163–167.
   PubMed Web of Science ®Google Scholar
• Yang M, Guo Y, Liu X, et al. HMGA1 promotes hepatic metastasis of colorectal cancer by inducing expression of glucose transporter 3 (GLUT3). Med Sci Monit. 2020;26:e924975.
   PubMed Web of Science ®Google Scholar
• Cao XP, Cao Y, Zhao H, et al. HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression. Biochem Biophys Res Commun. 2019;516(2):457–465.
   PubMed Web of Science ®Google Scholar
• Zanin R, Pegoraro S, Ros G, et al. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1. J Exp Clin Cancer Res. 2019;38(1):313.
   PubMedGoogle Scholar
• Quintavalle C, Burmeister K, Piscuoglio S, et al. High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy. Mol Carcinog. 2017;56(9):2146–2157.
   PubMed Web of Science ®Google Scholar
• Song J, Cui D, Wang J, et al. Overexpression of HMGA1 confers radioresistance by transactivating RAD51 in cholangiocarcinoma. Cell Death Discov. 2021;7(1):322.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Liu Y, Sun J, Qi P, et al. Long non-coding RNA titin-antisense RNA1 contributes to growth and metastasis of cholangiocarcinoma by suppressing microRNA-513a-5p to upregulate stratifin. Bioengineered. 2021;12(2):12611–12624.
   PubMed Web of Science ®Google Scholar
• Wei CX, Wong H, Xu F, et al. IRF4-induced upregulation of lncRNA SOX2-OT promotes cell proliferation and metastasis in cholangiocarcinoma by regulating SOX2 and PI3K/AKT signaling. Eur Rev Med Pharmacol Sci. 2018;22(23):8169–8178.
   PubMed Web of Science ®Google Scholar
• Gao J, Qin W, Kang P, et al. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma. Pathol Res Pract. 2020;216(1):152733.
   PubMed Web of Science ®Google Scholar
• Zhu H, Jiang X, Zhou X, et al. Neuropilin-1 regulated by miR-320 contributes to the growth and metastasis of cholangiocarcinoma cells. Liver Int. 2018;38(1):125–135.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhang Y, Ding M, et al. Long noncoding RNA TMPO-AS1/miR-126-5p/BRCC3 axis accelerates gastric cancer progression and angiogenesis via activating PI3K/Akt/mTOR pathway. J Gastroenterol Hepatol. 2021;36(7):1877–1888.
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the rosetta stone of a hidden RNA language? Cell. 2011;146(3):353–358.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhou M, Zou L, et al. Long non-coding RNA LOXL1-AS1 acts as a ceRNA for miR-324-3p to contribute to cholangiocarcinoma progression via modulation of ATP-binding cassette transporter A1. Biochem Biophys Res Commun. 2019;513(4):827–833.
   PubMed Web of Science ®Google Scholar
• Shah SN, Cope L, Poh W, et al. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells. PLoS One. 2013;8(5):e63419.
   PubMed Web of Science ®Google Scholar
• Belton A, Gabrovsky A, Bae YK, et al. HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells. PLoS One. 2012;7(1):e30034.
   PubMed Web of Science ®Google Scholar
• Hillion J, Roy S, Heydarian M, et al. The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors. Gynecol Oncol. 2016;141(3):580–587.
   PubMed Web of Science ®Google Scholar